REG - AstraZeneca PLC - Director/PDMR Shareholding <Origin Href="QuoteRef">AZN.L</Origin>
RNS Number : 0366ZAstraZeneca PLC23 May 2016Transaction by Person Discharging Managerial Responsibilities
Disclosure Rule DTR 3.1.4
On 23 May 2016, the interest of Luke Miels, a person discharging managerial responsibilities, in AstraZeneca PLC Ordinary Shares of $0.25 each changed as detailed below.
The change in interest relates to the vesting on 23 May 2016 of an award of shares granted in September 2014 under the AstraZeneca Restricted Share Plan. In accordance with the terms of the award, Mr Miels has become beneficially entitled to all of the shares originally awarded.
Sufficient vested shares have been withheld to cover certain tax obligations arising on the vesting and the net number of shares has been delivered into a personal brokerage account.
Plan
Shares awarded
Shares vested
Shares withheld
Net shares received
AstraZeneca Restricted Share Plan
7,776
7,776
2,524
5,252
For tax purposes, the fair market value of the shares at vest was 3894.5 pence per share being the closing price of AstraZeneca shares on the last trading day preceding the vesting day.
A C N Kemp
Company Secretary
23 May 2016
This information is provided by RNSThe company news service from the London Stock ExchangeENDDSHUOUORNNAVUAR
Recent news on AstraZeneca
See all newsRCS - LHH - LHH, EZRA's AI Leadership Transformation Program
AnnouncementREG - AstraZeneca PLC - Baxdrostat met primary endpoint in Bax24 Ph3 trial
AnnouncementREG - AstraZeneca PLC - Datroway improved OS and PFS in TROPION-Breast02
AnnouncementREG - AstraZeneca PLC - Total Voting Rights
AnnouncementREG - AstraZeneca PLC - Enhertu improved IDFS in early BC in DB-05
Announcement